| Jul 17 |
Longeveron® Announces U.S. FDA Grants Fast Track Designation for Lomecel-B™ for the Treatment of Mild Alzheimer’s Disease
|
| Jul 17 |
LGVN Gets Great FDA News for Alzheimer's Drug
|
| Jul 17 |
7 Meme Stocks That Deserve a Fresh Set of Eyes
|
| Jul 15 |
OTC Markets Hosts Virtual Investor Presentation with Wa’el Hashad, CEO of Longeveron, and Brad Sorensen, Senior Analyst at Zacks SCR
|
| Jul 10 |
Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
|
| Jul 10 |
Why Is Longeveron Stock Soaring On Wednesday?
|
| Jul 10 |
Longeveron scores RMAT designation for Alzheimer’s cell therapy
|
| Jul 10 |
Longeveron surges on key FDA designation for Alzheimer’s drug
|
| Jul 10 |
LGVN’s Alzheimer's Treatment Gets FDA Boost
|
| Jul 10 |
Longeveron® Announces U.S. FDA Grants Lomecel-B™ Regenerative Medicine Advanced Therapy (RMAT) Designation for the Treatment of Mild Alzheimer’s Disease
|
